Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment

Human Reproduction

Volumn 14, Issue 10, 1999, Pages 2665-2668

  Anderson, Richard A ^a   Kinniburgh, David ^a   Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer; GnRH antagonist; IVF; Ovulation induction

Indexed keywords

ANTINEOPLASTIC AGENT; CETRORELIX; CHORIONIC GONADOTROPIN; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOPRESERVATION; EMBRYO; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GONADOTROPIN RELEASE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEINIZATION; LUTEOLYSIS; OVULATION; OVULATION INDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

EID: 0032850496     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.10.2665     Document Type: Article

References (21)

1. Albano, C., Smitz, J., Camus, M. et al. (1996) Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix). Hum. Reprod., 11, 2114-2118.
2. Atkinson, H.G., Apperley, J.F., Dawson, K. et al. (1994) Successful pregnancy after embryo cryopreservation after BMT for CML. Lancet, 344, 199.
3. Bahadur, G. (1996) Posthumous assisted reproduction (PAR): cancer patients, potential cases, counselling and consent. Hum. Reprod., 11, 2573-2575.
4. Barnes, F.L., Crombie, A., Gardner, D.K. et al. (1995) Blastocyst development and birth after in-vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching. Hum. Reprod., 10, 3243-3247.
5. Blumenfeld, Z. and Haim, N. (1997) Prevention of gonadal damage during cytotoxic therapy. Ann. Med., 29, 199-206.
6. Diedrich, K., Diedrich, C., Santos, E. et al. (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum. Reprod., 9, 788-791.
7. Eppig, J.J. and O'Brien, M.J. (1996) Development in vitro of mouse oocytes from primordial follicles. Biol. Reprod., 54, 197-207.
8. Felberbaum, R., Reissmann, T., Kupker, W. et al. (1996) Hormone profiles under ovarian stimulation with human menopausal gonadotrophin (HMG) and concomitant administration of the gonadotrophin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages. J. Assist. Reprod. Genet., 13, 216-222.
9. Filicori, M., Cognigni, G.E., Arnone, R. et al. (1996) Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation. Hum. Reprod., 11, 123-132.
10. Fraser, H.M. and Bouchard, P. (1994) Control of the preovulatory luteinizing hormone surge by gonadotrophin-releasing hormone antagonists: prospects for clinical application. Trends Endocrinol Metab., 5, 87-93.
11. Gonzalez-Barcena, D., Vadillo Buenfil, M., Garcia Procel, E. et al. (1994) Inhibition of luteinizing hormone, follicle-stimulating hormone and sex steroid levels in men and women with a potent antagonist of luteinizing hormone-releasing hormone, Cetrorelix (SB-75). Eur. J. Endocrinol., 131, 286-292.
12. Gosden, R.G., Baird, D.T., Wade, J.C. and Webb, R. (1994) Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196°C. Hum. Reprod., 9, 597-603.
13. Howell, S. and Shalet, S. (1998) Gonadal damage from chemotherapy and radiotherapy. Endocrinol. Metab. Clin. N. Am., 27, 927-943.
14. Human Fertilisation and Embryology Authority (1997) Annual Report. HFEA, London.
15. Leroy, I., d'Acermont, M.F., Brailly-Tabard, S. et al. (1994) A single injection of a gonadotrophin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge. Fertil. Steril., 62, 461-467.
16. Meniru, G.I. and Craft, I. (1997) Assisted conception options for patients with good-prognosis cervical cancer. Lancet, 349, 542.
17. Newton, H., Aubard, Y., Rutherford, A. et al. (1996) Low temperature storage and grafting of human ovarian tissue. Hum. Reprod., 11, 1487-1491.
18. Paulson, R.J., Sauer, M.V. and Lobo, R.A. (1994) Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotrophins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience. J. Assist. Reprod. Genet., 11, 28-32.
19. Sauer, M.V., Paulson, R.J. and Lobo, R.A. (1997) Comparing the clinical utility of GnRH antagonist to GnRH agonist in an oocyte donation program. Gynaecol. Obstet. Invest., 42, 215-218.
20. Shaw, J.M., Bowles, J., Koopman, P. et al. (1996) Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum. Reprod., 11, 1668-1673.
21. Waxman, J.H., Ahmed, R., Smith, D. et al. (1987) Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother. Pharmacol., 19, 159-162.